Who invested in Sonexa Therapeutics?
Sonexa Therapeutics's investors include Scale Venture Partners, Domain Associates, Alta Partners, Mitsubishi Corporation and GeneChem.
United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$41Mraised across 5 rounds since 2008, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by sec.govSEC filing: $2.0M sold, first sale Aug 2012
No investor was named in the report.
Reported by sec.govSEC filing: $1.2M sold, first sale Mar 2012
No investor was named in the report.
Reported by sec.govSEC filing: $1000K sold, first sale Oct 2011
No investor was named in the report.
From a historical funding recordSEC filing: $37M sold, first sale Jan 2008
Reported by biospace.com
From the SEC filings it signed: 2 on the team.
On the board, as filediKim Puloma KamdarLouis C. BockRobert Alexander
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Sonexa Therapeutics's investors include Scale Venture Partners, Domain Associates, Alta Partners, Mitsubishi Corporation and GeneChem.
Sonexa Therapeutics has raised $41M across 5 rounds since 2008.
Sonexa Therapeutics's most recent round was a Debt of $2.0M in Aug 2012.
Sonexa Therapeutics's largest round on record is $30M (Series A), in Jan 2008.
Sonexa Therapeutics's first round on record, in Jan 2008, was backed by Scale Venture Partners, Domain Associates and Alta Partners and 2 others.
Sonexa Therapeutics's latest named round is a Debt, in Aug 2012.
Sonexa Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.